<DOC>
	<DOCNO>NCT00002472</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness cisplatin etoposide treat patient CNS tumor .</brief_summary>
	<brief_title>Cisplatin Etoposide Prior Radiation Therapy Treating Patients With CNS Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate patient newly diagnose CNS germ cell tumor treat cisplatin etoposide . - Determine survival patient CNS germ cell tumor treat cisplatin etoposide follow cranial radiotherapy . - Determine endocrine cognitive function patient receive regimen . OUTLINE : Patients stratify histology ( germinoma v nongerminoma ) . Patients receive cisplatin IV 4 hour follow etoposide IV 30-60 minute day 1-5 . Treatment continue every 3 week 4 course absence disease progression unacceptable toxicity . After completion 4 course , patient nongerminoma achieve complete response ( CR ) patient germinoma proceed radiotherapy . After completion 4 course , patient nongerminoma achieve less CR undergo resection residual cranial mass , feasible , proceed radiotherapy . Patients experience disease progression unacceptable toxicity chemotherapy restaged proceed directly radiotherapy . Beginning minimum 3 week completion last course chemotherapy recover toxic effect chemotherapy , eligible patient undergo regimen craniospinal axis irradiation and/or localize cranial spinal field irradiation base histology , extent disease , response chemotherapy . Patients gross spinal meningeal disease completion chemotherapy undergo radiotherapy boost . Patients follow every 2 month 1 year , every 4 month 1 year , every 6 month 1 year , annually 2 year . PROJECTED ACCRUAL : A total 12-25 patient germinoma accrue study within 3-6 year . A total 12-25 patient nongerminoma accrue study within 6-12 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven CNS germ cell tumor 1 follow subtypes : CNS germinoma Immature teratoma Embryonal cell carcinoma Yolk sac tumor Endodermal sinus tumor Choriocarcinoma OR Pineal suprasellar mass associate elevate CSF alpha fetoprotein betahuman chorionic gonadotropin allow Patients 18 year localized pure germinomas ineligible Evaluable CT MRI brain and/or spinal cord require PATIENT CHARACTERISTICS : Age : 3 Hematopoietic : Age 18 : WBC least 4,000/mm^3 Platelet count least 100,000/mm^3 Under age 18 : Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Not specify Renal : Creatinine great 0.3 mg/dL upper limit normal age Other : No uncontrolled infection Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy CNS germ cell tumor Endocrine therapy : Concurrent corticosteroid allow except antiemetic Radiotherapy : No prior cranial spinal radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>extragonadal germ cell tumor</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood central nervous system choriocarcinoma</keyword>
	<keyword>childhood central nervous system embryonal tumor</keyword>
	<keyword>childhood central nervous system germinoma</keyword>
	<keyword>childhood central nervous system mixed germ cell tumor</keyword>
	<keyword>childhood central nervous system teratoma</keyword>
	<keyword>childhood central nervous system yolk sac tumor</keyword>
</DOC>